HIV

ViiV Healthcare announces FDA approval of an expanded indication for Dovato (dolutegravir/lamivudine), a complete two-drug regimen for virologically suppressed adults with HIV-1

By
1 Mins read
134
0
Share
Reading Time: < 1 minute

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced Read More

134
0
Share
Related posts
HIV

Nigeria to receive HIV prevention drug in March, says NACA

By
1 Mins read
Reading Time: < 1 minuteThe National Agency for the Control of AIDS has announced that Nigeria will take delivery of Lenacapavir, a groundbreaking HIV prevention drug…
HIV

African HIV services face double blow of cuts from both Trump and UK

By
1 Mins read
Reading Time: < 1 minuteGroups fighting to prevent HIV on the ground in Senegal face a double blow of aid cuts – with Britain announcing a £150m cut to their biggest donor,…
HIV

North Carolina man accused of removing IV and ‘spraying HIV blood’ into hospital employees’ eyes

By
1 Mins read
Reading Time: < 1 minuteA North Carolina man was arrested nearly six months after he allegedly unhooked an IV from his arm and squirted HIV-positive blood…
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.